JPS605165A - 抗腫瘍性血液処理剤 - Google Patents

抗腫瘍性血液処理剤

Info

Publication number
JPS605165A
JPS605165A JP58111609A JP11160983A JPS605165A JP S605165 A JPS605165 A JP S605165A JP 58111609 A JP58111609 A JP 58111609A JP 11160983 A JP11160983 A JP 11160983A JP S605165 A JPS605165 A JP S605165A
Authority
JP
Japan
Prior art keywords
ribopolysaccharide
treating agent
gram
fiber
tumor blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58111609A
Other languages
English (en)
Japanese (ja)
Other versions
JPH043986B2 (da
Inventor
小玉　正智
徹 谷
水黒　知行
和雄 寺本
睦夫 村上
西海　四郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP58111609A priority Critical patent/JPS605165A/ja
Publication of JPS605165A publication Critical patent/JPS605165A/ja
Publication of JPH043986B2 publication Critical patent/JPH043986B2/ja
Granted legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP58111609A 1983-06-21 1983-06-21 抗腫瘍性血液処理剤 Granted JPS605165A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58111609A JPS605165A (ja) 1983-06-21 1983-06-21 抗腫瘍性血液処理剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58111609A JPS605165A (ja) 1983-06-21 1983-06-21 抗腫瘍性血液処理剤

Publications (2)

Publication Number Publication Date
JPS605165A true JPS605165A (ja) 1985-01-11
JPH043986B2 JPH043986B2 (da) 1992-01-24

Family

ID=14565674

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58111609A Granted JPS605165A (ja) 1983-06-21 1983-06-21 抗腫瘍性血液処理剤

Country Status (1)

Country Link
JP (1) JPS605165A (da)

Also Published As

Publication number Publication date
JPH043986B2 (da) 1992-01-24

Similar Documents

Publication Publication Date Title
Lett et al. Crosslinking and degradation of deoxyribonucleic acid gels with varying water contents when irradiated with electrons
Taylor et al. Protamine is an inhibitor of angiogenesis
Pearlstein Plasma membrane glycoprotein which mediates adhesion of fibroblasts to collagen
CN1161127C (zh) 交联的多糖药物载体
Drobnik Hyaluronan in drug delivery
JP3713276B2 (ja) 炎症反応の軽減のためのヘパリナーゼの使用
CA1233749A (en) Method for the therapeutic occlusion of blood vessels
Moolten et al. Antitumor effects of antibody-diphtheria toxin conjugates: Use of hapten-coated tumor cells as an antigenic target
JPS5959630A (ja) 特定抗原に特異的なモノクロ−ン抗体
CN117357693B (zh) 一种皮肤损伤修复水凝胶敷料及其制备方法
JPS6040859B2 (ja) 抗血栓性人工医療材料
Andersson Induction of immunity and immunologic paralysis in mice against polyvinyl pyrrolidone
Poznansky In vitro and in vivo activity of soluble cross-linked uricase-albumin polymers: a model for enzyme therapy
More et al. Immunological Induction of DNA Synthesis in Mouse Peritoneal Macrophages: An Expression of Cell-Mediated-Immunity
US5171738A (en) Method of treating malignant tumors
EP0107119A1 (en) Blood-treating material
US6262255B1 (en) Non-immunogenic, biocompatible macromolecular membrane compositions, and methods for making them
JPH043986B2 (da)
Comfort et al. The influence of bond chemistry on immobilized enzyme systems for ex vivo use
JP4252123B2 (ja) 固定化線維素溶解活性酵素の活性安定化法
JP3727074B2 (ja) 局所投与放射線治療剤
Bide et al. The Use of Dyeing Technology in Biomedical Applications.
JPS5964053A (ja) 血液処理剤およびその製造法
White et al. Studies on the cellular site of action of macrophage RNA-antigen complexes
JPH1189930A (ja) バルーン・カテーテル